Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of a Mind-Body Reprogramming Therapy vs. Care as Usual for Adolescents Aged 12-18 With Chronic Fatigue: A Randomized Controlled Trial.

NCT07923539 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07923539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of a Mind-Body Reprogramming Therapy vs. Care as Usual for Adolescents Aged 12-18 With Chronic Fatigue: A Randomized Controlled Trial.
Lead sponsor
Oslo University Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 9, 2026
Completion date
September 30, 2028
Enrollment
210 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic fatigue

Arms

As registered; 2 arms.

  • Care as Usual Active comparatorCare as usual

    These patients receive the standard treatment provided to this patient group at the respective study site.

  • Mind-Body Reprogramming Therapy ExperimentalMind-Body Reprogramming Therapy

    These patients receive Mind-Body Reprogramming Therapy (MBRT), as described in the attached protocol

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Chalder Fatigue Questionnare (CFQ) End of treatment at 3 months post-baseline.

    Total score on the CFQ, 0-33

Lead sponsor's other trials

Oslo University Hospital, most recent start first.